AstraZeneca

Αναστάτωση και σύγχυση με το εμβόλιο της AstraZeneca

naftemporiki.gr - 14 Jun 2021
Συνεχίζεται η σύγχυση με το σκεύασμα της AstraZeneca, καθώς χθες η Εθνική Επιτροπή των Εμβολιασμών εισηγήθηκε να διακοπεί η χορήγησή του στους πολίτες ...

• More

E. Χουλιάρα (AstraZeneca): Η φαρμακευτική καινοτομία είναι επένδυση για την υγεία, την κοινωνία και την οικονομία

BusinessNews.gr - 18 Apr 2024
E. Χουλιάρα (AstraZeneca): Η φαρμακευτική καινοτομία είναι επένδυση για την υγεία, την κοινωνία και την οικονομία  ...

• More

Έλενα Χουλιάρα: Η leader της AstraZeneca, ο «πόλεμος» και η νίκη

The Total Business - 15 Apr 2024
Έλενα Χουλιάρα: Η leader της AstraZeneca, ο «πόλεμος» και η νίκη  ...

• More

Χειρότερα των εκτιμήσεων τα εταιρικά αποτελέσματα της AstraZeneca – Τι λένε οι αναλυτές

Newmoney - 09 Feb 2024
Χειρότερα των εκτιμήσεων τα εταιρικά αποτελέσματα της AstraZeneca – Τι λένε οι αναλυτές  ...

• More

AstraZeneca Taps Bluecrux To Improve Lab Operations

Contract Pharma - 18 Apr 2024
AstraZeneca Taps Bluecrux To Improve Lab Operations  ...

• More

Proxy advisers inflict 'serious harm' to UK, says AstraZeneca chair

Financial Times - 14 Apr 2024
Proxy advisers inflict 'serious harm' to UK, says AstraZeneca chair  ...

• More

AstraZeneca rises Thursday, outperforms market

MarketWatch - 18 Apr 2024
AstraZeneca rises Thursday, outperforms market  ...

• More

AstraZeneca CEO set to earn £18.7 million after shareholder backing

Euronews - 12 Apr 2024
AstraZeneca CEO set to earn £18.7 million after shareholder backing  ...

• More

AstraZeneca cries havoc over CKD's hit on economies, environment

Fierce Pharma - 15 Apr 2024
AstraZeneca cries havoc over CKD's hit on economies, environment  ...

• More

AstraZeneca CEO 'massively underpaid' despite earning double Novo Nordisk boss

Fortune - 10 Apr 2024
AstraZeneca CEO 'massively underpaid' despite earning double Novo Nordisk boss  ...

• More

AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion

The Guardian - 11 Apr 2024
AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion  ...

• More

AstraZeneca's Impact CKD study: Alarming projections for 2032

outsourcing-pharma.com - 15 Apr 2024
AstraZeneca's Impact CKD study: Alarming projections for 2032  ...

• More

AstraZeneca's Imfinzi shows overall survival benefit in Phase III BTC trial

Clinical Trials Arena - 17 Apr 2024
AstraZeneca's Imfinzi shows overall survival benefit in Phase III BTC trial  ...

• More

AstraZeneca chair: UK business needs a level playing field to compete

Financial Times - 14 Apr 2024
AstraZeneca chair: UK business needs a level playing field to compete  ...

• More

AZ's Alexion debuts short film highlighting NMOSD community

Fierce Pharma - 18 Apr 2024
AZ's Alexion debuts short film highlighting NMOSD community  ...

• More

AstraZeneca falls Wednesday, underperforms market

MarketWatch - 17 Apr 2024
AstraZeneca falls Wednesday, underperforms market  ...

• More

AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt

Financial Times - 11 Apr 2024
AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt  ...

• More

AstraZeneca outperforms market despite losses on the day

MarketWatch - 16 Apr 2024
AstraZeneca outperforms market despite losses on the day  ...

• More

AstraZeneca's Pascal Soriot 'massively underpaid' at £16.9mn, says top shareholder

Financial Times - 09 Apr 2024
AstraZeneca's Pascal Soriot 'massively underpaid' at £16.9mn, says top shareholder  ...

• More

AstraZeneca shareholders urged to oppose pay plan for CEO Soriot

Financial Times - 30 Mar 2024
AstraZeneca shareholders urged to oppose pay plan for CEO Soriot  ...

• More